FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Analogue topics
Carbon Dioxide
Amino Acid
Radio Signal
Inorganic Compounds
Hydrogen Production From Water
Electrolysis
Semiconductor
High Energy
Semiconductor Material
Transmitter
Synchronization
Concurrent
Surfactant
Hyperglycemia
Pharmaceutically Acceptable Salt

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Analogue patents



      
           
This page is updated frequently with new Analogue-related patent applications. Subscribe to the Analogue RSS feed to automatically get the update: related Analogue RSS feeds. RSS updates for this page: Analogue RSS RSS


Sensor based means of monitoring the mechanical condition of rotating machinery that operates intermittently

Date/App# patent app List of recent Analogue-related patents
09/25/14
20140288962
 Multi-media medical notes system (mmmns) patent thumbnailnew patent Multi-media medical notes system (mmmns)
This invention develops a multi-media medical notes system (mmmns) that allows for the creation of the medical notes and integration with the medical records data bases. Its purpose is to provide an electronic format where the notes created during a patient's admission regarding daily examinations normally noted in analogue form could be organized to improve their presentation, accessibility, and integration.
09/25/14
20140288880
 Sensor based means of monitoring the mechanical condition of rotating machinery that operates intermittently patent thumbnailnew patent Sensor based means of monitoring the mechanical condition of rotating machinery that operates intermittently
A method of monitoring the mechanical condition of a machine in which statistically significant measurements on a characteristic signal are made over a period of time which can include interruptions and variations in the operation of the machine giving rise to uncharacteristic signals and the processing of the signal during the statistically significant measurement automatically excludes those parts of the signal associated with interruptions and variations in the operation of the machine. The invention also includes apparatus for carrying out the above method including a preamplifier, adapted to provide output to a further amplifier, adapted to provided output to dynamic enveloping circuitry, adapted to provide an output to an analogue to digital converter, adapted to provide an output to a digital micro-electronic device..
09/25/14
20140288862
 Magnetic compensation circuit and method for compensating the output of a magnetic sensor, responding to changes in a first magnetic field patent thumbnailnew patent Magnetic compensation circuit and method for compensating the output of a magnetic sensor, responding to changes in a first magnetic field
A solution for compensating a magnetic field sensor to permit detection of a small magnetic field in the presence of a large magnetic field is disclosed. A magnetic field sensor detects the magnetic field which produces an analogue signal then encoded by an analogue to digital converter (adc) into a digital stream.
09/25/14
20140288266
 Synthesis of cyclosporin analogs patent thumbnailnew patent Synthesis of cyclosporin analogs
The invention is directed to isomeric mixtures of cyclosporine analogues that are structurally similar to cyclosporine a. The mixtures possess enhanced efficacy and reduced toxicity over the individual isomers and over naturally occurring and other presently known cyclosporines and cyclosporine derivatives.
09/25/14
20140288052
 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators patent thumbnailnew patent Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.
09/25/14
20140287924
 Novel strigolactone analogues and their use patent thumbnailnew patent Novel strigolactone analogues and their use
Novel compounds of formula (i) their use as germination trap for parasitic weeds, for the regulation of branching, tillering and root development, for enhancement of cambium growth, for the regulation of hyphal growth of mycorrhizal fungi and compositions comprising compounds of formula (i) and insecticides and/or fungicides.. .
09/25/14
20140286895
 Methods and compositions for promoting organ development patent thumbnailnew patent Methods and compositions for promoting organ development
Compositions and methods are provided for promoting organ development in warm blooded animals, and in particular in certain aspects a premature infant or fetus. Compositions and methods are also provided for the administration of at least one colony stimulating factor-1 protein (csf-1), precursor, variant, analogue, derivative thereof, or combinations thereof, or otherwise, at least one nucleic acid molecule encoding colony stimulating factor-1 protein (csf-1), precursor, variant, analogue, derivative thereof, or combinations thereof..
09/18/14
20140275573
 Method of producing beraprost patent thumbnailMethod of producing beraprost
An improved method is described for making single isomers of synthetic benzoprostacyclin analogue compounds, in particular the pharmacologically active 314-d isomer of beraprost. In contrast to the prior art, the method is stereoselective and requires fewer steps than the known methods for making these compounds..
09/18/14
20140275541
 Total synthesis of thaxtomin a analogues and their intermediates patent thumbnailTotal synthesis of thaxtomin a analogues and their intermediates
Improved synthetic methods for the production of thaxtomin analogues, particularly thaxtomin a, and intermediates therefore such as substituted tryptophans and in particular, 4-nitro-l-tryptophan, and substituted phenyl acrylic acids are disclosed. Bioassays show that the synthetic thaxtomin a is not significantly different from the natural one in herbicidal activity..
09/18/14
20140275520
 Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof patent thumbnailProcess for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
And pharmaceutically acceptable salts thereof.. .
09/18/14
20140274939
Combined systemic and topical treatment of disordered tissues
Kits and methods for treating disordered tissue caused by a virus in a mammal involve co-administration of a systemic anti-virus drug and topically administering an anti-infective composition. The systemic anti-virus drug is internally administered and disrupts or inhibits virus replication systemically within the mammal.
09/18/14
20140271873
Application of encapsulated capsaicin and analogues thereof for controlling calorie intake
A zero-calorie to near-zero-calorie snacking product that, when consumed, provides a feeling of fullness prior to absorption of energy-providing food, i.e., pre-absorptive satiation is disclosed. The snacking product is based on the stimulation of vagal nerve endings in the gastro-intestinal tract by encapsulated capsaicin.
09/11/14
20140257590
Signal determination apparatus and temperature determination apparatus
A temperature determination apparatus includes a signal detection section having an a/d input port, a thermistor that is connected to the a/d input port and outputs an analogue signal to the a/d input port, and a switch section that shifts a level of the analogue signal to a low level. The signal detection section determines that a control signal having a priority higher than that of an output detection process of the thermistor is generated when it is detected that the analogue signal to be input to the a/d input port is in the low level..
09/11/14
20140256952
Process for ixabepilone, and intermediates thereof
The present invention relates to a novel process of making ixabepilone, ixabepilone derivatives and analogues, and intermediates thereof.. .
09/11/14
20140256922
Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds
The present disclosure provides novel imidazoquinoline derived compounds, derivatives thereof, analogues thereof, and pharmaceutically acceptable salts thereof, and methods of making and using such compounds. The present disclosure also provides tlr7 agonists and tlr7/tlr8 dual agonists, probes, tissue-specific molecules, adjuvants, immunogenic compositions, therapeutic compositions, and self-adjuvanting vaccines including the imidazoquinoline derived compounds, derivatives thereof, analogues thereof, and pharmaceutically acceptable salts thereof.
09/11/14
20140256794
Activation of functional nucleic acid by specific modification
This invention is intended to enhance and improve the resistance of a single- or double-stranded nucleic acid fragment comprising a base sequence of a functional nucleic acid to degradation by nucleolytic enzymes in a simple and cost-effective manner. The single- or double-stranded nucleic acid fragment comprises, ligated to at least one 3′ end thereof, a hairpin-shaped dna comprising: (a) a nucleic acid region consisting of 2 to 5 arbitrary nucleotides; (b) a nucleic acid region consisting of a “gna” or “gnna” base sequence, wherein each “n” represents “g”, “t”, “a”, or “c”, a base analogue, or a modified base; and (c) a nucleic acid region consisting of a base sequence complementary to the nucleic acid region (a), sequentially ligated from the 5′ end toward the 3′ end, wherein at least one of two 3′ terminal nucleotides from at least one 3′ end of the single-stranded nucleic acid fragment or the double-stranded nucleic acid fragment is modified..
09/11/14
20140256665
Aminoglycoside and azole compositions and methods
The present invention relates to novel fungicidal compound including an aminoglycoside analog having certain substituents at the 6 position of ring iii that exhibit improved antifungal activity but possess minimal antibacterial properties in combination with fungicidal azoles. The aminoglycoside compounds are analogues of kanamycin a.
09/11/14
20140256646
Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents
Disclosed herein are pace4 inhibitors, compositions comprising pace4 inhibitors and their uses thereof for lowering pace4 activity, reducing cell proliferation, reducing tumor growth, reducing metastasis formation, preventing and/or treating cancer. Also provided are methods for lowering pace4 activity, reducing the proliferation of a cell, reducing tumor growth and/or treating and preventing cancer.
09/11/14
20140256640
Treatment of coagulopathy with hyperfibrinolysis
The present invention relates to the use of thrombomodulin analogues for the manufacture of a medicament for the treatment of coagulopathy with hyperfibrinolysis, such as haemophilia disorders. These thrombomodulin analogs exhibit at therapeutically effective dosages an antifibrinolytic effect.
09/11/14
20140255991
Overexpression of aminoacyl-trna synthetases for efficient production of engineered proteins containing amino acid analogues
Methods for producing modified polypeptides containing amino acid analogues are disclosed. The invention further provides purified dihydrofolate reductase polypeptides, produced by the methods of the invention, in which the methionine residues have been replaced with homoallylglycine, homoproparglycine, norvaline, norleucine, cis-crotylglycine, trans-crotylglycine, 2-aminoheptanoic acid, 2-butynylglycine and allylglycine..
09/11/14
20140255591
Frozen dessert mixes using soy protein products
A soy protein product having a protein content of at least about 60 wt % (n×6.25) d.b., preferably at least about 90 wt %, and being completely soluble at ph values of less than about 4.4 and heat stable at such ph values is used to provide, at least in part, the protein component of a dairy analogue or plant/dairy blend frozen dessert mix.. .
09/11/14
20140253356
Digital-to-analogue converter
The invention relates to digital-to-analog converters for converting current. The converter includes a pair of differential branches with two transistors controlled by a digital register activated at a clock frequency, and two resistive loads receiving the currents of the differential branches to produce a differential electrical signal representing the analog result of the conversion.
09/11/14
20140253128
Fluid determination in a well bore
A fluid measurement system (10, 110, 210) and method of fluid mix determination over a sampling length (25) in a well bore (12). A pulse generator is nm in the well bore from which is suspended a cable (24) with two conductors having a length equal to the sampling length.
09/04/14
20140249194
Optically active fluconazole analogues containing thiophenes as antifungal agents
Wherein r5 is cn or coor′, where r′ is methyl or ethyl. The compounds of formula (1a) or formula (1b) may be used in pharmaceutical compositions for treating fungal infections..
09/04/14
20140249147
Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators
Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity.
09/04/14
20140249105
Novel ceramide analogues, processes for preparing same and uses thereof
Compounds, ceramide analogues, having a cyclic structure derived from cyclopropane, cyclobutane or cyclopentane, the ring bearing two chains consisting of an amide function. Each amide function is attached to the ring by the nitrogen atom of the function and carries a hydrocarbon chain derived from a fatty acid.
08/28/14
20140243765
Percutaneously absorbable preparation containing fentanyl and homologue thereof
Disclosed is a transdermal preparation, comprising sequentially-stacked layers of a backing layer, a barrier layer, a drug adhesive layer and a release layer, wherein the drug adhesive layer contains a drug selected from the group consisting of fentanyl, an analogue thereof and a pharmaceutically-acceptable salt thereof, a skin permeation enhancer of the drug, and a polyacrylate adhesive, which shows a high skin permeation with a low drug dosage, equivalent to one with high drug dosage, by increasing the skin permeation rate of drug.. .
08/28/14
20140243257
Benzimidazole analogues for the treatment or prevention of flavivirus infections
Or pharmaceutically acceptable salts and solvates thereof, wherein a, b, b′, x, y, r1, r1′, r2, r2′, r3, r3′, r5, r5′, r6, m, n, or p are as defined herein, are useful for treating flaviviridae viral infections.. .
08/28/14
20140242932
Multi-channel radio-frequency receiver
The invention relates to a multichannel radio-frequency receiver for electromagnetic waves, having a radio-frequency analogue section, which has an input for an electrical signal from a reception device, and having a lower-frequency section, which is connected downstream of the radiofrequency analogue section and has a plurality of parallel channels (6b, 6c; 7b, 7c) for in each case different signal levels and an evaluation circuit, in which, in the radiofrequency analogue section in order to split the signal in accordance with a predeterminable division ratio into signal elements which can be supplied to radio-frequency analogue channels (6a, 7a), downstream from which the channels (6b, 6c; 7b, 7c) of the lower-frequency section are respectively connected, and the channels (6b, 6c; 7b, 7c) of the lower-frequency section each have an evaluation circuit for detection of the phase and amplitude of the respective signal element.. .
08/28/14
20140242574
Codon-optimized gene for mutated shrimp luciferase and method for use thereof
There has been a demand for a codon-optimized gene for the mutated catalytic domain of oplophorus luciferase, which is capable of efficiently expressing a protein both in a cultured animal cell and escherichia coli. There has also been a demand for a substrate coelenterazine analogue showing a higher activity than that of native 19 kda protein.
08/28/14
20140242190
Use of deoxyelephantopin (det) and analogues thereof for treatment of melanoma
Methods for preventing and/or reducing side effects of an anti-cancer agent in a subject in need thereof are disclosed. The method comprises administering to the subject, who is under an anti-cancer agent treatment, a composition comprising a therapeutically effective amount of isolated deoxyelephantopin and/or an analogue thereof; and a pharmaceutically acceptable carrier..
08/28/14
20140242169
Tapentadol compositions
The present invention provides a method of treating pain and pain related conditions by administering to a patient in need thereof, a therapeutically effective amount of a slow release tapentadol hydrochloride and therapeutically effective amount of a second analgesic, wherein the second analgesic is gamma-aminobutyric acid (gaba) analogue. The present invention further provides a pharmaceutical composition comprising a therapeutically effective amount of a slow release tapentadol hydrochloride and a therapeutically effective amount of a second analgesic, wherein the second analgesic is gamma-aminobutyric acid (gaba) analogue..
08/28/14
20140242097
Methods
A method for promoting entry of an agent (introduced agent) into a cell, the method comprising the step of complexing the introduced agent in the presence of an entry-promoting agent and then exposing to cells, wherein the entry-promoting agent comprises a linear and/or branched or cyclic polymonoguanide/polyguanidine, polybiguanide, analogue or derivative thereof according to the following formula 1a & b. The method also provides a means for formation of nanoparticles formed between the entry promoting agent and the introduced agent.
08/28/14
20140240157
Analogue to digital converter
An analogue to digital converter (adc) having a gated ring voltage controlled oscillator, grvco, to generate a phase signal according to an input voltage; and a quantization circuit to generate a quantized phase output signal according. The grvco operates in either a first or second mode of operation according to a gating control signal.
08/21/14
20140235844
Short interfering rna (sirna) analogues
The present invention is directed to novel double-stranded short interfering (sirna) analogues comprising locked nucleic acid (lna) monomers. Such compounds induces sequence-specific post-transcriptional gene silencing in many organisms by a process known as rna interference (rnai).
08/21/14
20140235680
Desferrithiocin polyether analogues
Or a pharmaceutically acceptable salt thereof are useful in treating conditions such as metal overload, oxidative stress, and neoplastic and preneoplastic conditions.. .
08/21/14
20140235537
N-glycosylated insulin analogues
Compositions and formulations comprising n-glycosylated insulin analogues are described. In particular embodiments, the glycosylated insulin analogues are produced in vivo and comprise one or more the n-linked n-glycans selected from high mannose or fucosylated or non-fucosylated hybrid, paucimannose, or complex n-glycans.
08/21/14
20140234903
Biosynthetic gene cluster for the production of peptide/protein analogues
A novel gene cluster encoding polypeptides involved in the generation of bio synthetically unique peptide-based compounds is described. In addition, new methods for biosynthetic engineering and production of modified peptides and proteins are disclosed.
08/21/14
20140234251
Purine nucleoside analogues for treating flaviviridae including hepatitis c
This invention is directed to a method for treating a host, especially a human, infected with hepatitis c, flavivirus and/or pestivirus, comprising administering to that host an effective amount of an anti-hcv biologically active pentofuranonucleoside where the pentofuranonucleoside base is an optionally substituted 2-azapurine. The optionally substituted pentofuranonucleoside, or a salt or prodrug thereof, may be administered alone or in combination with one or more optionally substituted pentofuranonucleosides or other anti-viral agents..
08/21/14
20140234211
Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents
Delivery systems based on liposomes functionalized with peptides and chelating agents, for therapy and imaging by selective targeting of tumour cells expressing the receptors grp, bb1, bb2, bb3 e bb4 and any other receptor which recognizes the bombesin peptide or analogues thereof are described. In particular, the liposomes contain within them cytotoxic drugs, such as for example doxorubicin, for target-selective antitumour therapy, and, through the presence of the chelating agent, can contain radioactive or paramagnetic ions for the real time visualization of the tumour cells.
08/14/14
20140228375
Sigma receptors ligands with anti-apoptotic and/or pro-apoptotic properties, over cellular mechanisms, exhibiting prototypical cytoprotective and also anti-cancer activity
The present invention involves new and original sigma receptors ligands: (mono-or dialkylaminoalkyl)-γ-butyrolactones, their analogues aminotetrahydroturanes, the (1-adamantyl) benzene alkylamines, the n,n dialkyl α-[(adamantyl-1)benzyloxy-2] alkylamines and the 3-cyclopentyl adamantyl-amines or alkylamines or-alkyl phenylamines, their enantiomers or diastereoisomers, their pharmaceutically acceptable salts and quinacrine me-thylene blue, asteinizole and their relative analogues with pro-apoptotic and/or anti-apoptotic properties over cellular biochemical mechanisms, with prototypical anti-cancer, antimetastatic and antiviral activities associated with antagonism of the neuropatic pain and, at very low doses, with cytoprotective and cytoregenerative activity against the cytodegenerative diseases.. .
08/14/14
20140228364
Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
The present invention relates to a composition comprising at least one analogue of prostaglandin as active compound, and a stabilizing amount of at least one hyaluronic acid or a salt thereof, said composition being preservative-free; and to the use thereof for use in treating ocular hypertension and/or glaucoma in a subject in need thereof.. .
08/14/14
20140227231
Laminins, derivatives, and compositions including same and methods for their therapeutic use
In various embodiments, the present disclosure provides a method of treating a subject using laminin or a composition that includes laminin. In one embodiment, the method is used to enhance muscle regeneration, maintenance, or repair in a subject.
08/07/14
20140222365
Measuring transducer having two transmission channels
The inventions herein include a measuring transducer, having a first transmission channel which conditions an analogue measurement input signal in an analogue manner and makes it available as a conditioned measurement signal. In addition, the measuring transducer may have a second transmission channel which conditions the analogue measurement input signal and makes it available as an influencing signal, wherein the conditioned measurement signal and the influencing signal are combined and made available as a measurement output signal.
08/07/14
20140221961
Insertable medical device for delivering nano-carriers of mitomycin (and its analogues) to a target site, and methods for preparing and using the same
A nano-carrier comprising an antiproliferative drug encapsulated by a lipophilic enhancement agent.. .
08/07/14
20140221682
Synthesis and biological studies of an isomeric mixture of (e/z) isoxylitones and its analogues
The invention relates to an anti-epileptic isoxylitone, 2,2′-(3,5,5-trimethyl-2-cyclohexen-1-ylidene) acetic acid.. .
08/07/14
20140221639
Radiolabeled nucleoside analogue, and preparation method and use thereof
A radiolabeled nucleoside analogue is provided, which includes radioactive iodine 123i/131i, and a nucleoside analogue selected from a group consisting of cytidine, thymidine, uridine, and a derivative thereof. A method for preparing the radiolabeled nucleoside analogue, and a use thereof are further provided.
08/07/14
20140221627
Methods for preparation of fucose-linked site specific conjugates of proteins with toxins, adjuvants, detection labels and pharmacokinetic half life extenders
The present invention relates to eukaryotic cells for producing molecules having an atypical fucose analogue on their glycomoieties and/or amino acids. It also relates to methods for producing molecules having an atypical fucose analogue on their glycomoieties and/or amino acids and to molecules obtainable by said methods.
08/07/14
20140221473
Compositions, methods of use, and methods of treatment
Embodiments of the present disclosure provide compositions including ketamine analogues, salts, and disalts, pharmaceutical compositions including ketamine analogues, salts, or disalts, methods of treatment of a condition or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.. .
08/07/14
20140221394
Hydrobenzamide derivatives as inhibitors of hsp90
The invention provides an acid addition salt of a compound of the formula (1). Also provided by the invention are processes for preparing the compound of formula (1) and alkyl analogues thereof, novel intermediates for use in the process and methods for preparing the intermediates.
08/07/14
20140221364
Tetrahydroquinoline analogues as muscarinic agonists
The present invention relates to tetrahydroquinoline compounds as muscarinic receptor agonists; compositions comprising the same; methods of inhibiting an activity of a muscarinic receptor with said compounds; methods of treating a disease condition associated with a muscarinic receptor using said compounds; and methods for identifying a subject suitable for treatment using said compounds.. .
08/07/14
20140221285
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives
Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives are disclosed.. .
08/07/14
20140220392
Prussian blue analogue anodes for aqueous electrolyte batteries
A system and method producing electrodes in an aqueous electrolyte battery that maximizes energy storage, reduces electrochemical decomposition of the electrolyte, and uses prussian blue analogue materials for both electrodes, with an anode electrode including an electrochemically active hexacyanometalate group having two possible redox reactions of different potentials. These potentials may be tuned by substituting different electrochemically inactive components..
08/07/14
20140220128
Solid dosage form
A solid dosage form comprises coated particles of bisphosphonate or a pharmaceutically acceptable analogue or derivative thereof.. .
07/31/14
20140213618
Synthesis of epothilones, intermediates thereto and analogues thereof
As described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprising compounds of formula (i) and provides methods of treating cancer comprising administering a compound of formula (i)..
07/31/14
20140212383
Suppressor of the endogenous interferon-gamma
The invention relates to suppressors of endogenous human interferon-gamma (inf-γ) applicable in treatment of diseases associated with impaired activity of endogenous ifn-γ. The suppressors of the invention are useful in treating autoimmune diseases and for prevention of graft arteriosclerosis and rejection of organs in allograft transplanted patients.
07/24/14
20140206676
Substituted 4-(1h-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of machr m1 receptors
In one aspect, the invention relates to substituted 4-(1h-pyrazol-4-yl)benzyl analogs compounds, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor m1 (machr m1); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention..
07/24/14
20140206657
Bile acid analog tgr5 agonists
Provided herein are bile acid analogues and derivatives, methods of synthesizing bile acid analogues and derivatives and their use in treating diabetes and liver disease.. .
07/24/14
20140206604
4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
The variables are defined herein. Certain compounds of formula i are useful as antiviral agents.
07/24/14
20140206553
Massive parallel method for decoding dna and rna
This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of dna in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable linker, and a cleavable chemical group to cap the —oh group at the 3′-position of the deoxyribose..
07/24/14
20140205302
Photon phase modulating system
The present invention utilizes a high-speed serial data transceiver to generate two high-speed electric pulse signals. After passing through a gain network, the signals are used for driving an electro-optic phase modulator (pm) so as to realize phase modulation of photon signals.
07/24/14
20140203954
Adc testing
A histogram-based method for testing an electronic converter device, such as an analogue to digital converter, includes steps of defining at least one histogram hyperbin arranged to store hits for at least one subrange of output codes; applying an input test stimulus to an input of the device to test a subrange of output codes matched to the hyperbin; and accumulating the histogram. At least two hyperbins may be provided, each bin being arranged to store hits for at least one subrange of output codes, and the input test stimulus is applied to an input of the device to test a subrange of output codes matched to one of the hyperbins.


Popular terms: [SEARCH]

Analogue topics: Carbon Dioxide, Amino Acid, Radio Signal, Inorganic Compounds, Hydrogen Production From Water, Electrolysis, Semiconductor, High Energy, Semiconductor Material, Transmitter, Synchronization, Concurrent, Surfactant, Hyperglycemia, Pharmaceutically Acceptable Salt

Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Analogue for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Analogue with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.4357

3145

0 - 1 - 71